Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer (HFCBB)

National Taiwan University

Status: Enrolling

Conditions: Early Breast Cancer; Ductal Breast Carcinoma In Situ

Treatments: Radiation: Hypofractionated Radiation Therapy

Study type: Observational

Funder types: Other

Identifiers

NCT06984250

202110027RINB

113-S0087 (Other Grant/Funding Number)

Details and patient eligibility

About

Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy

Enrollment: 315 estimated patients

Sex: Female

Ages: 20 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female patients with histologically confirmed early-stage breast cancer (T1-2 and N0-1) or ductal carcinoma in situ (DCIS).
• Patients undergoing breast-conserving surgery
• Age ≥ 20 years
• Karnofsky Performance Status (KPS) ≥70%
• Life expectancy ≥ 5 years
• Adequate renal and hepatic function

Exclusion criteria

• Pregnant patients
• Patients requiring re-irradiation of the thoracic region

Trial design

315 participants in 1 patient group

CBB

Description:

Hypofractionated breast radiotherapy following partial mastectomy in patients with early breast cancer or ductal breast carcinoma in situ

Treatment:

Radiation: Hypofractionated Radiation Therapy